USF/c-Myc	B-protein
enhances	O
,	O
while	O
Yin-Yang	B-protein
1	I-protein
suppresses	O
,	O
the	O
promoter	O
activity	O
of	O
CXCR4	B-protein
,	O
a	O
coreceptor	B-protein
for	O
HIV-1	O
entry	O
.	O

Transcription	B-protein
factors	I-protein
USF1	B-protein
and	O
USF2	B-protein
up-regulate	O
gene	O
expression	O
(	O
i.e.	O
,	O
HIV-1	B-DNA
long	I-DNA
terminal	I-DNA
repeats	I-DNA
)	O
via	O
interaction	O
with	O
an	O
E	B-DNA
box	I-DNA
on	O
their	O
target	O
promoters	O
,	O
which	O
is	O
also	O
a	O
binding	B-DNA
site	I-DNA
for	O
c-Myc	B-protein
.	O

The	O
c-Myc	B-protein
oncoprotein	I-protein
is	O
important	O
in	O
control	O
of	O
cellular	O
proliferation	O
and	O
differentiation	O
,	O
while	O
Yin-Yang	B-protein
1	I-protein
(	O
YY1	B-protein
)	O
has	O
been	O
shown	O
to	O
control	O
the	O
expression	O
of	O
a	O
number	O
of	O
cellular	B-DNA
and	I-DNA
viral	I-DNA
genes	I-DNA
.	O

These	O
two	O
proteins	O
physically	O
interact	O
with	O
each	O
other	O
and	O
mutually	O
inhibit	O
their	O
respective	O
biological	O
functions	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
USF/c-Myc	B-protein
up-regulates	O
,	O
while	O
YY1	B-protein
down-regulates	O
the	O
promoter	O
activity	O
of	O
CXCR4	B-protein
,	O
a	O
coreceptor	O
for	O
T	O
cell-tropic	O
HIV-1	O
entry	O
.	O

We	O
have	O
identified	O
an	O
E	B-DNA
box	I-DNA
around	O
-260	B-DNA
and	O
a	O
YY1	B-DNA
binding	I-DNA
site	I-DNA
around	O
-300	B-DNA
relative	O
to	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
.	O

Mutation	O
of	O
the	O
E	B-DNA
box	I-DNA
abolished	O
USF/c-Myc	B-protein
-mediated	O
up-regulation	O
of	O
CXCR4	B-protein
promoter	O
activity	O
,	O
and	O
mutation	O
of	O
the	O
YY1	B-DNA
binding	I-DNA
site	I-DNA
was	O
associated	O
with	O
unresponsiveness	O
to	O
YY1	B-protein
-mediated	O
inhibition	O
.	O

These	O
data	O
suggest	O
that	O
USF/c-Myc	B-protein
and	O
YY1	B-protein
may	O
play	O
an	O
important	O
role	O
in	O
the	O
HIV-1-replicative	O
cycle	O
,	O
by	O
modulating	O
both	O
the	O
viral	O
fusion/entry	O
process	O
and	O
viral	O
expression	O
.	O

'_9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Wiki	NULL
-	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
C5a	NULL
,	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
QuIpEeL	NULL
MULTIPLEX	NULL
I	NULL
-	NULL
Mie	NULL
/	NULL
(	NULL
ty	NULL
ay	NULL
2	NULL
Sa	NULL
reJournal	NULL
o	NULL
USF/c-Myc	NULL
Enhances	NULL
,	NULL
While	NULL
Yin-Yang	NULL
1	NULL
Y	NULL
Suppresses	NULL
,	NULL
the	NULL
Promoter	NULL
Activity	NULL
of	NULL
CXCR4	NULL
ImmunOIOgy	NULL
a	NULL
Coreceptzn	NULL
’	NULL
for	NULL
HIV-1	NULL
Entry	NULL
'	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Masako	NULL
Moriuchi	NULL
,	NULL
Hiroyuki	NULL
Moriuch1	NULL
,	NULL
David	NULL
M.	NULL
Margolis	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019.	NULL
and	NULL
Anthony	NULL
S.	NULL
Fauci	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:5986-5992	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/10/5986	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
41	NULL
articles	NULL
,	NULL
26	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/10/5986.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
USF/c-Myc	NULL
Enhances	NULL
,	NULL
While	NULL
Yin-Yang	NULL
1	NULL
Suppresses	NULL
,	NULL
the	NULL
Promoter	NULL
Activity	NULL
of	NULL
CXCR4	NULL
,	NULL
a	NULL
Coreceptor	NULL
for	NULL
HIV-1	NULL
Entry	NULL
Masako	NULL
Moriuchi	NULL
,	NULL
'*	NULL
Hiroyuki	NULL
Moriuchi	NULL
,	NULL
``	NULL
*	NULL
David	NULL
M.	NULL
Margolis	NULL
,	NULL
``	NULL
and	NULL
Anthony	NULL
S.	NULL
Fauci*	NULL
Transcription	NULL
factors	NULL
USF1	NULL
and	NULL
USF2	NULL
up-regulate	NULL
gene	NULL
expression	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeats	NULL
)	NULL
via	NULL
interaction	NULL
with	NULL
an	NULL
E	NULL
box	NULL
on	NULL
their	NULL
target	NULL
promoters	NULL
,	NULL
which	NULL
is	NULL
also	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
c-Myc	NULL
.	NULL

The	NULL
c-Myc	NULL
oncoprotein	NULL
is	NULL
important	NULL
in	NULL
control	NULL
of	NULL
cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
,	NULL
while	NULL
Yin-Yang	NULL
1	NULL
(	NULL
YY1	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
physically	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
and	NULL
mutually	NULL
inhibit	NULL
their	NULL
respective	NULL
biological	NULL
functions	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
USF/c-Myc	NULL
up-regulates	NULL
,	NULL
while	NULL
YY1	NULL
down-regulates	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
CXCR4	NULL
,	NULL
a	NULL
coreceptor	NULL
for	NULL
T	NULL
cell-tropic	NULL
HIV-1	NULL
entry	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
an	NULL
E	NULL
box	NULL
around	NULL
-260	NULL
and	NULL
a	NULL
YY1	NULL
binding	NULL
site	NULL
around	NULL
-300	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
E	NULL
box	NULL
abolished	NULL
USF/c-Myc-mediated	NULL
up-regulation	NULL
of	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
was	NULL
associated	NULL
with	NULL
unresponsiveness	NULL
to	NULL
YY1-mediated	NULL
inhibition	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
USF/c-Mye	NULL
and	NULL
YY1	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
HIV-1-replicative	NULL
cycle	NULL
,	NULL
by	NULL
modulating	NULL
both	NULL
the	NULL
viral	NULL
fusion/entry	NULL
process	NULL
and	NULL
viral	NULL
expression	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
1621	NULL
5986-5992.	NULL
number	NULL
of	NULL
cellular	NULL
factors	NULL
of	NULL
the	NULL
host	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
replication	NULL
of	NULL
HIV-1	NULL
at	NULL
various	NULL
steps	NULL
of	NULL
the	NULL
viral	NULL
replication	NULL
cycle	NULL
(	NULL
1	NULL
)	NULL
.	NULL

At	NULL
the	NULL
level	NULL
of	NULL
viral	NULL
expression	NULL
,	NULL
numerous	NULL
cellular	NULL
transcription	NULL
factors	NULL
regulate	NULL
transcription	NULL
from	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
``	NULL
the	NULL
promoter	NULL
of	NULL
HIV-1	NULL
.	NULL

While	NULL
many	NULL
of	NULL
these	NULL
factors	NULL
(	NULL
ie	NULL
.	NULL

,	NULL
nuclear	NULL
factor-	NULL
«	NULL
B/Rel	NULL
family	NULL
proteins	NULL
(	NULL
2	NULL
)	NULL
,	NULL
C/EBP	NULL
(	NULL
NF-IL6	NULL
)	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
,	NULL
Sp1	NULL
(	NULL
5	NULL
)	NULL
,	NULL
or	NULL
USF	NULL
(	NULL
6	NULL
)	NULL
)	NULL
enhance	NULL
LTR	NULL
activity	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

7	NULL
)	NULL
,	NULL
a	NULL
few	NULL
factors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
directly	NULL
reduce	NULL
HIV	NULL
expression	NULL
at	NULL
the	NULL
promoter	NULL
level	NULL
.	NULL

YY1	NULL
,	NULL
a	NULL
multifunctional	NULL
transcription	NULL
factor	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
repress	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
gene	NULL
promoters	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
,	NULL
including	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Host	NULL
cell	NULL
factors	NULL
also	NULL
affect	NULL
HIV	NULL
at	NULL
earlier	NULL
steps	NULL
in	NULL
its	NULL
replication	NULL
cycle	NULL
.	NULL

HIV-1	NULL
entry	NULL
into	NULL
cells	NULL
requires	NULL
the	NULL
CD4	NULL
molecule	NULL
as	NULL
well	NULL
as	NULL
a	NULL
fusion/entry	NULL
cofactor	NULL
(	NULL
11-18	NULL
)	NULL
.	NULL

Several	NULL
chemokine	NULL
receptors	NULL
serve	NULL
as	NULL
fusion/entry	NULL
cofactors	NULL
,	NULL
among	NULL
which	NULL
CXCR4	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
CXC	NULL
chemokine	NULL
stromal-derived	NULL
factor	NULL
(	NULL
SDF-1	NULL
)	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
is	NULL
a	NULL
major	NULL
fusion/entry	NULL
cofactor	NULL
for	NULL
T	NULL
cell-tropic	NULL
HIV-1	NULL
.	NULL

Functional	NULL
expression	NULL
of	NULL
CXCR4	NULL
is	NULL
influenced	NULL
by	NULL
other	NULL
host	NULL
cell	NULL
factors	NULL
.	NULL

SDF-1	NULL
,	NULL
a	NULL
ligand	NULL
of	NULL
CXCR4	NULL
,	NULL
regulates	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CXCR4	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
whereas	NULL
IL-2	NULL
regulates	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
CXCR4	NULL
mRNA	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
cloned	NULL
and	NULL
analyzed	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
CXCR4	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
found	NULL
that	NULL
two	NULL
transcription	NULL
factors	NULL
,	NULL
nuclear	NULL
respiratory	NULL
factor-1	NULL
(	NULL
NRF-1	NULL
)	NULL
and	NULL
Spl	NULL
,	NULL
interact	NULL
with	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
and	NULL
that	NULL
the	NULL
former	NULL
is	NULL
critical	NULL
for	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
.	NULL

CXCR4	NULL
expression	NULL
on	NULL
*Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Dis-eases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
;	NULL
and	NULL
*Institute	NULL
of	NULL
Human	NULL
Virology	NULL
,	NULL
University	NULL
of	NULL
Maryland	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21201	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
2	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
February	NULL
16	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
M.M	NULL
.	NULL

and	NULL
H.M.	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
project	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
H.	NULL
Moriuchi	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Nagasaki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
1-7-1	NULL
Sakamoto	NULL
,	NULL
Nagasaki	NULL
852-8501	NULL
,	NULL
Japan	NULL
.	NULL

°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
bHLHZip	NULL
,	NULL
basic	NULL
re-gion-helix-loop-helix-zipper	NULL
;	NULL
CyPA	NULL
,	NULL
cyclophilin	NULL
A	NULL
;	NULL
NRF-1	NULL
,	NULL
nuclear	NULL
respiratory	NULL
factor-1	NULL
;	NULL
SDF-1	NULL
,	NULL
stromal-derived	NULL
factor-1	NULL
;	NULL
TSS	NULL
,	NULL
transcription	NULL
start	NULL
site	NULL
;	NULL
YY1	NULL
,	NULL
Yin-Yang	NULL
1	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
monocytes	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
down-regulated	NULL
upon	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
mature	NULL
macrophages	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
characterize	NULL
the	NULL
further	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
.	NULL

We	NULL
report	NULL
that	NULL
USF/c-Mye	NULL
and	NULL
YY1	NULL
bind	NULL
to	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
and	NULL
positively	NULL
or	NULL
negatively	NULL
regulate	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
respectively	NULL
.	NULL

Involvement	NULL
of	NULL
USF	NULL
and	NULL
YY1	NULL
at	NULL
two	NULL
critical	NULL
steps	NULL
of	NULL
HIV-1	NULL
replication	NULL
,	NULL
viral	NULL
fusion/entry	NULL
and	NULL
expression	NULL
,	NULL
suggests	NULL
that	NULL
these	NULL
transcription	NULL
factors	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV	NULL
disease	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Plasmids	NULL
Plasmid	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
contains	NULL
the	NULL
CXCR4	NULL
upstream	NULL
sequence	NULL
between	NULL
-357	NULL
and	NULL
+51	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
TSS	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Plasmids	NULL
pGL-CXCR4AE	NULL
box	NULL
and	NULL
pGL-CXCR4AYY1	NULL
were	NULL
constructed	NULL
by	NULL
PCR-based	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
26	NULL
)	NULL
to	NULL
generate	NULL
mutations	NULL
on	NULL
an	NULL
E	NULL
box	NULL
around	NULL
-260	NULL
and	NULL
on	NULL
a	NULL
YY1	NULL
binding	NULL
site	NULL
around	NULL
-300	NULL
relative	NULL
to	NULL
the	NULL
TSS	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
and	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Plasmid	NULL
pBpuro-c-myc-ER	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
T.	NULL
D.	NULL
Littlewood	NULL
,	NULL
Imperical	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
London	NULL
,	NULL
U.K.	NULL
)	NULL
encodes	NULL
human	NULL
c-Myc	NULL
fused	NULL
to	NULL
the	NULL
hormone-binding	NULL
domain	NULL
of	NULL
the	NULL
mutant	NULL
murine	NULL
estrogen	NULL
receptor	NULL
.	NULL

Functional	NULL
expression	NULL
of	NULL
a	NULL
c-Myc	NULL
fusion	NULL
protein	NULL
by	NULL
the	NULL
transfected	NULL
plasmid	NULL
is	NULL
induced	NULL
by	NULL
4-hydroxytamoxifen	NULL
(	NULL
10	NULL
nM	NULL
;	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Plasmids	NULL
pCMV-Myc	NULL
and	NULL
pCMV-Max	NULL
were	NULL
gifts	NULL
of	NULL
D.	NULL
Ayer	NULL
(	NULL
University	NULL
of	NULL
Utah	NULL
,	NULL
Salt	NULL
Lake	NULL
City	NULL
,	NULL
UT	NULL
)	NULL
(	NULL
28	NULL
)	NULL
and	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
synthesis	NULL
of	NULL
c-Myc	NULL
and	NULL
Max	NULL
proteins	NULL
.	NULL

USF	NULL
expression	NULL
plasmids	NULL
pSV-USF1	NULL
and	NULL
pSV-USF2	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Sawadogo	NULL
(	NULL
University	NULL
of	NULL
Texas	NULL
M.	NULL
D.	NULL
Anderson	NULL
Cancer	NULL
Center	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
a	NULL
YY1	NULL
expression	NULL
plasmid	NULL
pCMV-YY1	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
T.	NULL
Shenk	NULL
(	NULL
Princeton	NULL
University	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Cells	NULL
PBMC	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteers	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

A3.01	NULL
human	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
propagated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Transfection	NULL
,	NULL
and	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
assays	NULL
Transient	NULL
expression	NULL
and	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Probes	NULL
used	NULL
for	NULL
DNase	NULL
I	NULL
footprinting	NULL
were	NULL
prepared	NULL
as	NULL
follows	NULL
:	NULL
a	NULL
Miul-Sacl	NULL
fragment	NULL
and	NULL
a	NULL
Miul-SphI	NULL
fragment	NULL
of	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
using	NULL
Klenow	NULL
enzyme	NULL
and	NULL
gel	NULL
purified	NULL
.	NULL

These	NULL
fragments	NULL
span	NULL
the	NULL
CXCR4	NULL
promoter	NULL
sequence	NULL
between	NULL
-357	NULL
and	NULL
-277	NULL
,	NULL
and	NULL
between	NULL
-283	NULL
and	NULL
-46	NULL
,	NULL
respectively	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
TSS	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
CXCR4	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Oligonucleotides	NULL
used	NULL
for	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
``	NULL
Oligonucleotide	NULL
Sequence	NULL
L-E	NULL
box	NULL
5'-TGCTAGCTTCCCACCTGTCTTCAGGCGCATC-3	NULL
'	NULL
ACGATCGAAGGGTGGACAGAAGTCCGCGTAG	NULL
5'-TGCTAGCTTCCTGTCTGTCTTCAGGCGCATC-3	NULL
'	NULL
ACGATCGAAGCACAGACAGAAGTCCGCGTAG	NULL
L-E	NULL
box-m	NULL
E	NULL
box	NULL
5'-GGAAGCAGACCACGTGGTCTGCTTCC-3	NULL
``	NULL
CCTTCGTCTGGTGCACCAGACGAAGG	NULL
L-YY1	NULL
5'-TAGCAAGGATGGACGCGCCACAGAGAGAC-3	NULL
``	NULL
ATCGTTCCTACCTGCGCGGTGTCTCTCTG	NULL
L-YYl-ml	NULL
-	NULL
5'-TAGCAAGGATCCACGCGCCACAGAGAGAC-3	NULL
'	NULL
ATCGTTCCTAGGTGCGCGGTGTCTCTCTG	NULL
L-YY1-m2	NULL
-	NULL
5'-TAGCAAGGATGGACGCGCCACCTAGAGAC-3	NULL
'	NULL
ATCGTTCCTACCTGCGCGGTGGATCTCTG	NULL
YY1	NULL
5'-CGCTCCGCGGCcaTCTTGececcTecT-3	NULL
'	NULL
GCGAGGCGCCGGTAGAACCGCCGACCA	NULL
GATA	NULL
5'-CACTTGATAACAGAAAGTGATAACTCT-3	NULL
'	NULL
GTGAACTATTGTCTTTCACTATTGAGA	NULL
STAT	NULL
5'-GTATTTCCCAGAAAAGGAAC-3	NULL
``	NULL
CATAAAGGGTCTITTCCTTG	NULL
``	NULL
Sequences	NULL
corresponding	NULL
to	NULL
cis-acting	NULL
elements	NULL
are	NULL
underlined	NULL
.	NULL

Mutated	NULL
nucle-otides	NULL
are	NULL
shown	NULL
in	NULL
bold	NULL
letters	NULL
.	NULL

Oligonucleotides	NULL
E	NULL
box	NULL
,	NULL
YY1	NULL
,	NULL
GATA	NULL
,	NULL
and	NULL
STAT	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

promoter	NULL
sequence	NULL
spanning	NULL
from	NULL
-357	NULL
and	NULL
-156	NULL
relative	NULL
to	NULL
the	NULL
TSS	NULL
was	NULL
amplified	NULL
with	NULL
PCR	NULL
and	NULL
subcloned	NULL
into	NULL
pCR2.1	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
a	NULL
Spel-EcoRV	NULL
fragment	NULL
of	NULL
the	NULL
resultant	NULL
plasmid	NULL
(	NULL
in	NULL
which	NULL
the	NULL
Spel	NULL
site	NULL
is	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
sequence	NULL
position	NULL
-156	NULL
)	NULL
was	NULL
°°P	NULL
labeled	NULL
and	NULL
purified	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
extracts	NULL
,	NULL
propagation	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
gel-mobility	NULL
shift	NULL
assays	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
A3.01	NULL
cells	NULL
or	NULL
U937	NULL
cells	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

c-Myc	NULL
,	NULL
Max	NULL
,	NULL
USF-1	NULL
,	NULL
and	NULL
USF-2	NULL
proteins	NULL
were	NULL
synthesized	NULL
in	NULL
vitro	NULL
from	NULL
pCMV-Myc	NULL
,	NULL
pCMV-Max	NULL
,	NULL
pSV-USF1	NULL
,	NULL
and	NULL
pSV-USF2	NULL
,	NULL
respectively	NULL
,	NULL
using	NULL
T7	NULL
RNA	NULL
polymerase/Wheat	NULL
Germ	NULL
Extract	NULL
System	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
rYY1	NULL
protein	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Gel-mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Antisera	NULL
used	NULL
for	NULL
supershift	NULL
assays	NULL
were	NULL
the	NULL
following	NULL
:	NULL
normal	NULL
rabbit	NULL
serum	NULL
,	NULL
anti-YY1	NULL
rabbit	NULL
polyclonal	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-c-Myc	NULL
rabbit	NULL
polyclonal	NULL
Ab	NULL
(	NULL
Santa	NULL
Cruz	NULL
A	NULL
FIGURE	NULL
1	NULL
.	NULL

-	NULL
Schematic	NULL
diagram	NULL
of	NULL
350	NULL
~800	NULL
the	NULL
CXCR4	NULL
upstream	NULL
sequence	NULL
.	NULL

Top	NULL
,	NULL
The	NULL
horizontal	NULL
arrows	NULL
indicate	NULL
the	NULL
SRF	NULL
NF-	NULL
«	NULL
B	NULL
YY1	NULL
Myc/USF	NULL
STAT	NULL
NFAT/AP1	NULL
VDR	NULL
AP1	NULL
SP1	NULL
5987	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-USE-1	NULL
,	NULL
or	NULL
anti-USF2	NULL
rabbit	NULL
polyclonal	NULL
Ab	NULL
(	NULL
provided	NULL
by	NULL
M.	NULL
Sawadogo	NULL
)	NULL
.	NULL

Results	NULL
Identification	NULL
of	NULL
putative	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
First	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
binding	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
region	NULL
between	NULL
-350	NULL
and	NULL
-150	NULL
relative	NULL
to	NULL
the	NULL
TSS	NULL
in	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

Among	NULL
areas	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
regions	NULL
around	NULL
-260	NULL
(	NULL
FP-5	NULL
)	NULL
and	NULL
-300	NULL
(	NULL
FP-6	NULL
)	NULL
were	NULL
found	NULL
to	NULL
share	NULL
homology	NULL
to	NULL
an	NULL
E	NULL
box	NULL
(	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
basic	NULL
region-helix-loop-helix-leucine	NULL
zipper	NULL
(	NULL
bHLHZip	NULL
)	NULL
family	NULL
proteins	NULL
(	NULL
35	NULL
)	NULL
)	NULL
and	NULL
a	NULL
YY1	NULL
binding	NULL
site	NULL
(	NULL
8	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

bHLHZip	NULL
proteins	NULL
c-Myc	NULL
,	NULL
USF-1	NULL
,	NULL
and	NULL
USF-2	NULL
bind	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
To	NULL
demonstrate	NULL
that	NULL
the	NULL
putative	NULL
E	NULL
box	NULL
in	NULL
the	NULL
CXCR4	NULL
promoter	NULL
region	NULL
actually	NULL
serves	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
bHLHZip	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
gel-mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
in	NULL
vitro	NULL
synthesized	NULL
proteins	NULL
.	NULL

Either	NULL
c-Myc/Max	NULL
,	NULL
USF-1	NULL
,	NULL
or	NULL
USE-2	NULL
protein	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
an	NULL
L-E	NULL
box	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
FP-5	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
;	NULL
however	NULL
,	NULL
c-Myc/Max	NULL
complex	NULL
was	NULL
detectable	NULL
only	NULL
after	NULL
longer	NULL
exposure	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

c-Myc	NULL
protein	NULL
alone	NULL
could	NULL
not	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
L-E	NULL
box	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
most	NULL
likely	NULL
reflecting	NULL
the	NULL
fact	NULL
that	NULL
Max	NULL
protein	NULL
is	NULL
an	NULL
obligate	NULL
heterodimeric	NULL
partner	NULL
for	NULL
c-Myc	NULL
(	NULL
35	NULL
)	NULL
.	NULL

When	NULL
A3.01	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
instead	NULL
of	NULL
purified	NULL
proteins	NULL
,	NULL
a	NULL
DNA-protein	NULL
complex	NULL
,	NULL
which	NULL
was	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
probe	NULL
as	NULL
well	NULL
as	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
E	NULL
box	NULL
,	NULL
was	NULL
formed	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Supershift	NULL
assays	NULL
using	NULL
specific	NULL
Abs	NULL
to	NULL
c-Myc	NULL
,	NULL
USF1	NULL
,	NULL
or	NULL
USF2	NULL
indicated	NULL
that	NULL
the	NULL
major	NULL
complex	NULL
contained	NULL
both	NULL
USF1	NULL
and	NULL
USF2	NULL
,	NULL
but	NULL
not	NULL
c-Myc	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
bHLHZip	NULL
proteins	NULL
c-Myc	NULL
,	NULL
USF1	NULL
,	NULL
and	NULL
USF2	NULL
bind	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
E	NULL
box	NULL
;	NULL
however	NULL
,	NULL
USF1	NULL
and	NULL
USF2	NULL
have	NULL
higher	NULL
affinity	NULL
for	NULL
the	NULL
E	NULL
box	NULL
than	NULL
does	NULL
c-Myc	NULL
.	NULL

-250	NULL
-200	NULL
-150	NULL
=100	NULL
-50	NULL
SP1	NULL
SP1	NULL
NRF	NULL
]	NULL
'	NULL
r	NULL
transcription	NULL
start	NULL
sites	NULL
(	NULL
TSS	NULL
)	NULL
,	NULL
and	NULL
numbers	NULL
above	NULL
the	NULL
sequence	NULL
indicate	NULL
nucleotide	NULL
relative	NULL
to	NULL
the	NULL
most	NULL
5	NULL
'	NULL
TSS	NULL
.	NULL

Sequences	NULL
homologous	NULL
to	NULL
bind-	NULL
B	NULL
ing	NULL
sites	NULL
for	NULL
cellular	NULL
transcription	NULL
fac-	NULL
tors	NULL
NRF-1	NULL
,	NULL
Sp1	NULL
,	NULL
AP-1	NULL
,	NULL
vitamin	NULL
D	NULL
re-	NULL
-350	NULL
SRF	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
:	NULL
ceptor	NULL
,	NULL
NF-AT/AP-1	NULL
,	NULL
STAT	NULL
,	NULL
c-Myc/	NULL
CTCTACTGTAGCATTCCCAGGTCTGGAATTCCATCCACTTTAGCAAGCGATG	NULL
USF	NULL
,	NULL
YY1	NULL
,	NULL
nuclear	NULL
factor-B	NULL
,	NULL
and	NULL
FP-7	NULL
FP-6	NULL
serum-responsive	NULL
factor	NULL
are	NULL
indi-	NULL
E	NULL
box	NULL
-250	NULL
cated	NULL
.	NULL

Boftom	NULL
,	NULL
The	NULL
areas	NULL
protected	NULL
GACGCGCCACAGAGAGACGCGTTCCTAGCCCGCGCTTCCCACCTGTCTTCA	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
(	NULL
FP-1	NULL
FP-5	NULL
through	NULL
FP-7	NULL
)	NULL
are	NULL
indicated	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

STAT	NULL
.	NULL

NFAT/AP1	NULL
VDR	NULL
-200	NULL
2	NULL
)	NULL
.	NULL

An	NULL
E	NULL
box	NULL
and	NULL
a	NULL
YY1	NULL
binding	NULL
site	NULL
GGCGCATCCCGCTTCCCTCAAACTTAGGAAATGCCTCTGGGAGGTCCTGTC	NULL
are	NULL
shown	NULL
as	NULL
italic	NULL
letters	NULL
,	NULL
and	NULL
muta-	NULL
FP-4	NULL
FP-3	NULL
FP-2	NULL
tions	NULL
in	NULL
pGL-CXCR4AE	NULL
box	NULL
and	NULL
AP1	NULL
-150	NULL
pGL-CXCR4AYY1	NULL
are	NULL
shown	NULL
by	NULL
the	NULL
CGGCTCCGGACTCACTACCGACCACCCGCAAACAGCAGGGTCCCCTGGCGCT	NULL
downward	NULL
arrows	NULL
(	NULL
also	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

FP-1	NULL
-100	NULL
I	NULL
TCCCAAGCCGCGCACCTCTCCGCCCCGCCCCTGCGCCCTCCTTCC	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5988	NULL
REGULATION	NULL
OF	NULL
CXCR4	NULL
PROMOTER	NULL
BY	NULL
USF/c-Mye	NULL
AND	NULL
YY1	NULL
a	NULL
<	NULL
I	NULL
G	NULL
u	NULL
+	NULL
@	NULL
w	NULL
O0	NULL
m	NULL
2	NULL
0	NULL
m	NULL
2	NULL
-184	NULL
»	NULL
-290	NULL
>	NULL
»	NULL
q	NULL
l	NULL
«	NULL
s	NULL
32	NULL
=	NULL
w	NULL
die	NULL
<	NULL
+	NULL
.	NULL

4	NULL
4	NULL
<	NULL
7	NULL
:	NULL
w	NULL
=	NULL
:	NULL
]	NULL
¢	NULL
;	NULL
G	NULL
im	NULL
Z	NULL
St	NULL
f	NULL
©	NULL
F	NULL
-350	NULL
>	NULL
sise	NULL
J	NULL
i	NULL
[	NULL
raf	NULL
wa	NULL
s	NULL
H	NULL
i	NULL
¥	NULL
C	NULL
JE	NULL
LL	NULL
L	NULL
:	NULL
ny	NULL
H	NULL
Ts	NULL
&	NULL
h	NULL
a.	NULL
al	NULL
-	NULL
.u_	NULL
te	NULL
ea	NULL
-	NULL
v-	NULL
&	NULL
%	NULL
.—	NULL
]	NULL
d_	NULL
)	NULL
#	NULL
1	NULL
we	NULL
LL	NULL
m	NULL
«	NULL
ten	NULL
*	NULL
«	NULL
#	NULL
as	NULL
**	NULL
.	NULL

m	NULL
**	NULL
**	NULL
5	NULL
.	NULL

Sie	NULL
T	NULL
a	NULL
If	NULL
'	NULL
3	NULL
u	NULL
#	NULL
RF	NULL
&	NULL
-156	NULL
>	NULL
sae	NULL
.	NULL

aan	NULL
aan	NULL
-262	NULL
>	NULL
-290	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
FIGURE	NULL
2	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
A3.01	NULL
cells	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
,	NULL
G+A	NULL
chemical	NULL
cleavage	NULL
ladder	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
,	NULL
DNA	NULL
fragment	NULL
pattern	NULL
generated	NULL
by	NULL
DNase	NULL
I	NULL
treatment	NULL
after	NULL
incubation	NULL
of	NULL
a	NULL
5	NULL
'	NULL
end-labeled	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
BSA	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
(	NULL
NE	NULL
)	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Positions	NULL
relative	NULL
to	NULL
the	NULL
TSS	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
Zeff	NULL
.	NULL

The	NULL
boxes	NULL
and	NULL
dots	NULL
on	NULL
the	NULL
right	NULL
indicate	NULL
the	NULL
protected	NULL
regions	NULL
(	NULL
FP-1	NULL
through	NULL
7	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
bottom	NULL
)	NULL
)	NULL
and	NULL
the	NULL
hypersensitive	NULL
nucleotides	NULL
,	NULL
respectively	NULL
.	NULL

X	NULL
©	NULL
A	NULL
SHE	NULL
B	NULL
0	NULL
``	NULL
0	NULL
=	NULL
S	NULL
E	NULL
moa	NULL
CE	NULL
g	NULL
lL	NULL
L	NULL
6	NULL
<	NULL
6	NULL
1	NULL
a	NULL
J	NULL
o	NULL
o	NULL
o	NULL
2	NULL
I	NULL
Competitor	NULL
:	NULL
I	NULL
an	NULL
“	NULL
:	NULL
EP	NULL
.	NULL

1	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
``	NULL
cts	NULL
Hits	NULL
cam	NULL
Wis	NULL
cate	NULL
C.D	NULL
.	NULL

2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
bHLHZip	NULL
proteins	NULL
c-Myc	NULL
,	NULL
USF-1	NULL
,	NULL
and	NULL
USF-2	NULL
up-regulate	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
To	NULL
investigate	NULL
whether	NULL
bHLHZip	NULL
proteins	NULL
c-Myc	NULL
,	NULL
USF1	NULL
,	NULL
and	NULL
USF2	NULL
,	NULL
which	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
are	NULL
capable	NULL
of	NULL
regulating	NULL
expression	NULL
from	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
expression	NULL
vectors	NULL
for	NULL
these	NULL
proteins	NULL
were	NULL
cotransfected	NULL
with	NULL
CXCR4	NULL
promoter-luciferase	NULL
reporter	NULL
constructs	NULL
.	NULL

Transfection	NULL
of	NULL
c-Myc	NULL
up-regulated	NULL
expression	NULL
from	NULL
the	NULL
CXCR4	NULL
promoter	NULL
;	NULL
this	NULL
effect	NULL
was	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
E	NULL
box	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
the	NULL
Max	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
further	NULL
enhance	NULL
c-Myc-medi-ated	NULL
transactivation	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
probably	NULL
because	NULL
Max	NULL
is	NULL
constitutively	NULL
and	NULL
abundantly	NULL
expressed	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

USF1	NULL
,	NULL
and	NULL
to	NULL
a	NULL
slightly	NULL
lesser	NULL
extent	NULL
,	NULL
USF2	NULL
,	NULL
also	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
reporter	NULL
gene	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
E	NULL
box	NULL
ablated	NULL
this	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

YY	NULL
]	NULL
binds	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
To	NULL
determine	NULL
whether	NULL
YY1	NULL
actually	NULL
binds	NULL
to	NULL
the	NULL
region	NULL
,	NULL
gel-mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
bacterially	NULL
synthesized	NULL
YY1	NULL
protein	NULL
.	NULL

Purified	NULL
YY1	NULL
protein	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
FP-6	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

A3.01	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
two	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
FP-6	NULL
region	NULL
,	NULL
which	NULL
were	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
probe	NULL
;	NULL
a	NULL
fast	NULL
migrating	NULL
complex	NULL
,	NULL
but	NULL
not	NULL
a	NULL
slowly	NULL
migrating	NULL
complex	NULL
,	NULL
was	NULL
also	NULL
specifically	NULL
competed	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
YY1	NULL
binding	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
;	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Gel-shift	NULL
interference	NULL
assays	NULL
using	NULL
anti-YY1	NULL
Ab	NULL
confirmed	NULL
that	NULL
the	NULL
fast	NULL
migrating	NULL
complex	NULL
contains	NULL
YY1	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
YY1	NULL
binds	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
.	NULL

A	NULL
slowly	NULL
migrating	NULL
complex	NULL
was	NULL
specifically	NULL
competed	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
GATA	NULL
binding	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
;	NULL
however	NULL
,	NULL
Ab	NULL
to	NULL
GATA1	NULL
,	NULL
GATAZ	NULL
,	NULL
or	NULL
GATA3	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
mobility	NULL
or	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
FP-6	NULL
region	NULL
has	NULL
only	NULL
limited	NULL
homology	NULL
to	NULL
C	NULL
L-E	NULL
box	NULL
L-E	NULL
box-m	NULL
E	NULL
box	NULL
GATA	NULL
Anti-c-Myc	NULL
Control	NULL
Anti-USF1	NULL
Anti-USF2	NULL
Ab	NULL
:	NULL
&	NULL
i	NULL
A	NULL
~	NULL
A	NULL
Itrel	NULL
cp	NULL
.	NULL

2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIGURE	NULL
3.	NULL
bHLHZip	NULL
proteins	NULL
c-Myc	NULL
,	NULL
USF1	NULL
,	NULL
and	NULL
USF2	NULL
bind	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
In	NULL
vitro	NULL
synthesized	NULL
c-Myc	NULL
,	NULL
USF1	NULL
,	NULL
and	NULL
USF2	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
E	NULL
box	NULL
in	NULL
CXCR4	NULL
promoter	NULL
.	NULL

L-E	NULL
box	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
in	NULL
vitro	NULL
synthesized	NULL
c-Myc/Max	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
USF-1	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
USF2	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
control	NULL
reaction	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
4	NULL
represent	NULL
probe	NULL
alone	NULL
.	NULL

Arrows	NULL
and	NULL
F.	NULL
P.	NULL
indicate	NULL
DNA-protein	NULL
complexes	NULL
and	NULL
free	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
Gel-mobility	NULL
shift	NULL
and	NULL
competition	NULL
assays	NULL
.	NULL

L-E	NULL
box	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
nonlabeled	NULL
oligonucleotides	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
indicated	NULL
above	NULL
the	NULL
figure	NULL
as	NULL
competitors	NULL
.	NULL

Lane	NULL
7	NULL
represents	NULL
probe	NULL
alone	NULL
,	NULL
and	NULL
lanes	NULL
2-6	NULL
represent	NULL
reactions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
arrow	NULL
represents	NULL
the	NULL
DNA-protein	NULL
complex	NULL
.	NULL

C	NULL
,	NULL
Supershift	NULL
assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
A3.01	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
Abs	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
incubation	NULL
with	NULL
L-E	NULL
box	NULL
probe	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
USF	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
solid	NULL
and	NULL
open	NULL
circles	NULL
indicate	NULL
the	NULL
shift	NULL
of	NULL
USF1	NULL
and	NULL
USF2	NULL
complexes	NULL
,	NULL
respectively	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
4.	NULL
bHLHZip	NULL
proteins	NULL
c-Myc	NULL
,	NULL
A	NULL
USF1	NULL
,	NULL
and	NULL
USF2	NULL
up-regulate	NULL
CXCR4	NULL
pro-	NULL
6	NULL
;	NULL
moter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
c-Myc	NULL
up-regulates	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
.	NULL

Forty	NULL
million	NULL
PBMCs	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
either	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
or	NULL
pGL-CXCR4AE	NULL
box	NULL
along	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pBpuro-c-myc-ER	NULL
,	NULL
and	NULL
either	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
Myc	NULL
)	NULL
with	NULL
10	NULL
nM	NULL
of	NULL
4-hydroxytamoxifen	NULL
(	NULL
Sigma	NULL
)	NULL
24	NULL
h	NULL
after	NULL
4r	NULL
transfection	NULL
.	NULL

4-Hydroxytamoxifen	NULL
at	NULL
this	NULL
concentration	NULL
by	NULL
itself	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

Fold	NULL
induction	NULL
indicates	NULL
luciferase	NULL
activity	NULL
relative	NULL
to	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

Results	NULL
were	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
USF1	NULL
and	NULL
USF2	NULL
up-regulate	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
.	NULL

PBMC	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
pug	NULL
of	NULL
either	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
or	NULL
pGL-CXCR4AE	NULL
box	NULL
along	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
either	NULL
pSV2-CAT	NULL
,	NULL
pSV-USF1	NULL
,	NULL
or	NULL
pSV-USF2	NULL
.	NULL

Results	NULL
were	NULL
represen-	NULL
0	NULL
tative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

S	NULL
Fold	NULL
Induction	NULL
to	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
GATA	NULL
binding	NULL
motif	NULL
.	NULL

Identification	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
currently	NULL
in	NULL
progress	NULL
.	NULL

YY	NULL
]	NULL
suppresses	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
In	NULL
the	NULL
context	NULL
of	NULL
other	NULL
promoters	NULL
,	NULL
YY1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
,	NULL
repress	NULL
transcription	NULL
,	NULL
or	NULL
initiate	NULL
transcription	NULL
(	NULL
re-	NULL
A	NULL
B	NULL
YY1	NULL
Control	NULL
L-YY¥1	NULL
L-YY1-mi	NULL
Competitor	NULL
:	NULL
|	NULL
L-YY1-m2	NULL
5989	NULL
8	NULL
~	NULL
BB	NULL
Control	NULL
BBB	NULL
Control	NULL
c-Myc	NULL
USFi	NULL
USF2	NULL
6	NULL
#	NULL
g	NULL
J	NULL
¢	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
Fold	NULL
Induction	NULL
A	NULL
pGL-CXCR4AE	NULL
box	NULL
pGL-CXCR4AE	NULL
box	NULL
viewed	NULL
by	NULL
Shrivastava	NULL
and	NULL
Calame	NULL
,	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
how	NULL
YY1	NULL
regulates	NULL
activity	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
we	NULL
transfected	NULL
A3.01	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
CXCR4	NULL
promoter/luciferase	NULL
reporter	NULL
construct	NULL
along	NULL
with	NULL
a	NULL
YY1	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
immediately	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
tested	NULL
for	NULL
luciferase	NULL
C	NULL
8	NULL
&	NULL
&	NULL
&	NULL
§	NULL
©	NULL
z	NULL
4	NULL
&	NULL
Ab	NULL
:	NULL
|	NULL
0	NULL
<	NULL
>	NULL
-	NULL
D	NULL
®	NULL
tuag	NULL
wan	NULL
we	NULL
)	NULL
<	NULL
3	NULL
whus	NULL
<	NULL
+	NULL
-	NULL
<	NULL
@	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIGURE	NULL
5	NULL
.	NULL

YY	NULL
!	NULL

binds	NULL
to	NULL
CXCR4	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
In	NULL
vitro	NULL
synthesized	NULL
YY1	NULL
protein	NULL
binds	NULL
to	NULL
CXCR4	NULL
promoter	NULL
.	NULL

L-YY1	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
in	NULL
vitro	NULL
synthesized	NULL
YY1	NULL
protein	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
BSA	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
as	NULL
a	NULL
control	NULL
.	NULL

B	NULL
,	NULL
Gel-mobility	NULL
shift	NULL
and	NULL
competition	NULL
assays	NULL
.	NULL

L-	NULL
YY1	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
nonlabeled	NULL
oligonucleotides	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
indicated	NULL
above	NULL
the	NULL
figure	NULL
as	NULL
competitors	NULL
.	NULL

Lane	NULL
7	NULL
represents	NULL
probe	NULL
alone	NULL
,	NULL
and	NULL
Zares	NULL
2-8	NULL
represent	NULL
reactions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
.	NULL

F.	NULL
P.	NULL
indicates	NULL
free	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
solid	NULL
and	NULL
open	NULL
arrows	NULL
indicate	NULL
the	NULL
YY1	NULL
complex	NULL
(	NULL
see	NULL
C	NULL
)	NULL
and	NULL
another	NULL
uncharacterized	NULL
protein-DNA	NULL
complex	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
,	NULL
Gel-shift	NULL
interference	NULL
analysis	NULL
with	NULL
anti-YY1	NULL
Ab	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
for	NULL
binding	NULL
between	NULL
L-YY1	NULL
oligonucleotide	NULL
and	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
was	NULL
incubated	NULL
with	NULL
either	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
anti-YY1	NULL
rabbit	NULL
polyclonal	NULL
Ab	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
solid	NULL
arrows	NULL
indicate	NULL
the	NULL
YY1	NULL
complex	NULL
,	NULL
which	NULL
was	NULL
disrupted	NULL
by	NULL
anti-	NULL
YY1	NULL
Ab	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
not	NULL
control	NULL
serum	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
represents	NULL
probe	NULL
alone	NULL
,	NULL
and	NULL
lanes	NULL
2-4	NULL
represent	NULL
reactions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
A3.01	NULL
nuclear	NULL
extracts	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5990	NULL
REGULATION	NULL
OF	NULL
CXCR4	NULL
PROMOTER	NULL
BY	NULL
USF/c-Mye	NULL
AND	NULL
YY1	NULL
activity	NULL
2	NULL
days	NULL
later	NULL
.	NULL

Overexpression	NULL
of	NULL
YY1	NULL
suppressed	NULL
the	NULL
CXCR4	NULL
promoter	NULL
in	NULL
A3.01	NULL
cells	NULL
up	NULL
to	NULL
80	NULL
%	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
on	NULL
the	NULL
CXCR4	NULL
promoter	NULL
sequence	NULL
involves	NULL
YY1-mediated	NULL
repression	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
,	NULL
site-directed	NULL
mutations	NULL
were	NULL
introduced	NULL
on	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
its	NULL
activity	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
wild-type	NULL
promoter	NULL
.	NULL

An	NULL
oligonucleotide	NULL
with	NULL
mutations	NULL
on	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
(	NULL
L-YY1-m1	NULL
in	NULL
Table	NULL
I	NULL
)	NULL
lost	NULL
its	NULL
ability	NULL
to	NULL
disrupt	NULL
the	NULL
YY1	NULL
complex	NULL
formation	NULL
in	NULL
gel-mobility	NULL
shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Introduction	NULL
of	NULL
mutations	NULL
into	NULL
the	NULL
CXCR4	NULL
promoter/luciferase	NULL
reporter	NULL
construct	NULL
resulted	NULL
in	NULL
approximately	NULL
a	NULL
2-fold	NULL
increase	NULL
in	NULL
the	NULL
basal	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
and	NULL
its	NULL
activity	NULL
was	NULL
not	NULL
markedly	NULL
influenced	NULL
by	NULL
cotransfection	NULL
with	NULL
the	NULL
YY1	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
YY1	NULL
inhibits	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CXCR4	NULL
promoter	NULL
through	NULL
its	NULL
binding	NULL
to	NULL
a	NULL
site	NULL
around	NULL
-300	NULL
relative	NULL
to	NULL
the	NULL
TSS	NULL
.	NULL

c-Myc	NULL
and	NULL
YY1	NULL
mutually	NULL
inhibit	NULL
the	NULL
transregulatory	NULL
functions	NULL
on	NULL
the	NULL
CXCR4	NULL
promoter	NULL
YY1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
physically	NULL
associate	NULL
with	NULL
c-Myc	NULL
,	NULL
and	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
two	NULL
proteins	NULL
appears	NULL
to	NULL
result	NULL
in	NULL
mutual	NULL
inhibition	NULL
of	NULL
their	NULL
transregulatory	NULL
functions	NULL
(	NULL
37	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
mutually	NULL
affect	NULL
their	NULL
functions	NULL
related	NULL
to	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
,	NULL
expression	NULL
vectors	NULL
for	NULL
YY1	NULL
and	NULL
c-Myc	NULL
were	NULL
transfected	NULL
into	NULL
A3.01	NULL
cells	NULL
individually	NULL
or	NULL
in	NULL
combination	NULL
along	NULL
with	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
above	NULL
,	NULL
overexpression	NULL
of	NULL
YY1	NULL
repressed	NULL
,	NULL
while	NULL
c-Myc	NULL
transactivated	NULL
,	NULL
the	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
;	NULL
however	NULL
,	NULL
the	NULL
net	NULL
effect	NULL
of	NULL
the	NULL
cotransfection	NULL
of	NULL
both	NULL
expression	NULL
vectors	NULL
on	NULL
the	NULL
promoter	NULL
was	NULL
negligible	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
implying	NULL
their	NULL
mutually	NULL
inhibitory	NULL
interaction	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
cellular	NULL
YY1	NULL
transcription	NULL
factor	NULL
down-regulates	NULL
CXCR4	NULL
expression	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
CXCR4	NULL
promoter	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
with	NULL
IL-2	NULL
or	NULL
anti-CD3	NULL
Ab	NULL
increased	NULL
CXCR4	NULL
expression	NULL
(	NULL
24	NULL
,	NULL
36	NULL
)	NULL
,	NULL
and	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
NRF-1	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
(	NULL
24	NULL
)	NULL
.	NULL

YY1	NULL
is	NULL
the	NULL
first	NULL
cellular	NULL
factor	NULL
to	NULL
be	NULL
identified	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
CXCR4	NULL
expression	NULL
.	NULL

YY1	NULL
is	NULL
widely	NULL
expressed	NULL
and	NULL
highly	NULL
conserved	NULL
among	NULL
mammalian	NULL
species	NULL
,	NULL
and	NULL
thus	NULL
can	NULL
be	NULL
categorized	NULL
as	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
(	NULL
8	NULL
,	NULL
30	NULL
)	NULL
.	NULL

YY1	NULL
can	NULL
directly	NULL
interact	NULL
with	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
proteins	NULL
and	NULL
regulates	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
promoters	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
gene	NULL
as	NULL
well	NULL
as	NULL
the	NULL
cell	NULL
type	NULL
in	NULL
question	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
YY1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
c-Myc	NULL
protein	NULL
,	NULL
and	NULL
this	NULL
association	NULL
may	NULL
lead	NULL
to	NULL
mutual	NULL
inhibition	NULL
of	NULL
the	NULL
transcription	NULL
functions	NULL
of	NULL
both	NULL
proteins	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
c-Myc	NULL
protein	NULL
is	NULL
a	NULL
potent	NULL
regulator	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
c-Myc	NULL
expression	NULL
is	NULL
down-regulated	NULL
upon	NULL
differentiation	NULL
of	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
into	NULL
more	NULL
mature	NULL
phenotypes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Considering	NULL
the	NULL
relatively	NULL
weak	NULL
affinity	NULL
of	NULL
c-Myc	NULL
protein	NULL
to	NULL
the	NULL
CXCR4	NULL
promoter	NULL
E	NULL
box	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
this	NULL
oncoprotein	NULL
may	NULL
activate	NULL
CXCR4	NULL
promoter	NULL
primarily	NULL
through	NULL
the	NULL
relief	NULL
of	NULL
repression	NULL
mediated	NULL
by	NULL
YY1	NULL
,	NULL
as	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
other	NULL
promoter	NULL
contexts	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Our	NULL
hypothesis	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
c-Myc	NULL
,	NULL
other	NULL
bHLHZip	NULL
transcription	NULL
factors	NULL
,	NULL
USF1	NULL
and	NULL
USF2	NULL
,	NULL
which	NULL
have	NULL
higher	NULL
affinity	NULL
for	NULL
the	NULL
CXCR4	NULL
promoter	NULL
E	NULL
box	NULL
than	NULL
does	NULL
c-Myc	NULL
and	NULL
are	NULL
not	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
YY	NULL
1	NULL
,	NULL
appear	NULL
to	NULL
act	NULL
through	NULL
their	NULL
direct	NULL
binding	NULL
to	NULL
the	NULL
E	NULL
box	NULL
.	NULL

Other	NULL
cellular	NULL
proteins	NULL
associated	NULL
with	NULL
YY1	NULL
include	NULL
cyclophilin	NULL
A	NULL
(	NULL
CyPA	NULL
)	NULL
and	NULL
FK506-binding	NULL
protein	NULL
12	NULL
(	NULL
39	NULL
)	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
specifically	NULL
interact	NULL
with	NULL
YY1	NULL
and	NULL
alter	NULL
its	NULL
transcriptional	NULL
activity	NULL
,	NULL
A	NULL
120	NULL
100	NULL
|-	NULL
>	NULL
=	NULL
80	NULL
}	NULL
O	NULL
<	NULL
I	NULL
@	NULL
PA	NULL
§	NULL
£	NULL
60	NULL
}	NULL
'	NULL
o	NULL
3	NULL
_I	NULL
@	NULL
2	NULL
®	NULL
40	NULL
}	NULL
0	NULL
oc	NULL
C	NULL
wT	NULL
®	NULL
ayyi	NULL
20	NULL
|-o	NULL
1	NULL
i	NULL
1	NULL
1	NULL
1	NULL
0	NULL
1	NULL
5	NULL
25	NULL
(	NULL
ug	NULL
)	NULL
pCMV-Y¥1	NULL
200	NULL
-	NULL
EBB	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
pGL-CXCRaa¥v1	NULL
pGL-CXCRA4AE	NULL
box	NULL
150	NULL
;	NULL
100	NULL
|	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
50	NULL
;	NULL
0	NULL
FIGURE	NULL
6	NULL
.	NULL

YY1	NULL
represses	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
Overexpression	NULL
of	NULL
YY1	NULL
down-regulates	NULL
CXCR4	NULL
promoter	NULL
.	NULL

A3.01	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
either	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
(	NULL
)	NULL
)	NULL
or	NULL
pGL-CXCR4AYY1	NULL
(	NULL
@	NULL
)	NULL
along	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
pCMV-YY1	NULL
.	NULL

Total	NULL
amounts	NULL
of	NULL
transfected	NULL
plasmid	NULL
DNA	NULL
were	NULL
adjusted	NULL
by	NULL
adding	NULL
pCMV	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
without	NULL
any	NULL
stimulation	NULL
,	NULL
and	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

Representative	NULL
results	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
Mutation	NULL
on	NULL
the	NULL
YY1	NULL
binding	NULL
site	NULL
increases	NULL
CXCR4	NULL
promoter	NULL
activity	NULL
.	NULL

A3.01	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
either	NULL
pGL-CXCR4	NULL
(	NULL
-357	NULL
)	NULL
,	NULL
pGL-CXCR4AYY1	NULL
,	NULL
or	NULL
pGL-CXCR4AE	NULL
box	NULL
as	NULL
well	NULL
as	NULL
10	NULL
g	NULL
of	NULL
pCMV-B-gal	NULL
,	NULL
incubated	NULL
without	NULL
any	NULL
stimulation	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
cell	NULL
lysates	NULL
were	NULL
standardized	NULL
by	NULL
B-galactosidase	NULL
activity	NULL
in	NULL
the	NULL
lysates	NULL
.	NULL

Results	NULL
are	NULL
means	NULL
and	NULL
SDs	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
2.5	NULL
EB	NULL
Control	NULL
c-Myc	NULL
i	NULL
2.0	NULL
|	NULL
c-Myc+YY1	NULL
_s	NULL
in	NULL
Fold	NULL
Induction	NULL
3	NULL
0.5	NULL
FIGURE	NULL
7.	NULL
c-Myc	NULL
and	NULL
YY1	NULL
mutually	NULL
inhibit	NULL
the	NULL
transregulatory	NULL
functions	NULL
on	NULL
the	NULL
CXCR4	NULL
promoter	NULL
.	NULL

Forty	NULL
million	NULL
PBMCs	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pGL-CXCRA4	NULL
(	NULL
-357	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
pBpuro-c-myc-ER	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
either	NULL
pCMV	NULL
or	NULL
pCMV-YY1	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
Myc	NULL
)	NULL
with	NULL
10	NULL
nM	NULL
of	NULL
4-hydroxytamoxifen	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

Fold	NULL
induction	NULL
indicates	NULL
luciferase	NULL
activity	NULL
relative	NULL
to	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

Results	NULL
were	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

and	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
efficiently	NULL
disrupt	NULL
the	NULL
YY1-CyPA	NULL
and	NULL
YY1-FK506-binding	NULL
protein	NULL
12	NULL
interactions	NULL
,	NULL
respectively	NULL
(	NULL
39	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
CyPA	NULL
binds	NULL
the	NULL
HIV-1	NULL
Gag	NULL
protein	NULL
,	NULL
is	NULL
specifically	NULL
incorporated	NULL
into	NULL
HIV-1	NULL
virion	NULL
particles	NULL
,	NULL
and	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
uncoating	NULL
of	NULL
the	NULL
virions	NULL
after	NULL
cellular	NULL
entry	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
YY1	NULL
influences	NULL
maturation	NULL
and	NULL
uncoating	NULL
of	NULL
the	NULL
HIV-1	NULL
virions	NULL
through	NULL
interaction	NULL
with	NULL
CyPA	NULL
.	NULL

Furthermore	NULL
,	NULL
YY1	NULL
is	NULL
one	NULL
of	NULL
a	NULL
few	NULL
cellular	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
repress	NULL
HIV	NULL
LTR	NULL
transcription	NULL
activity	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
YY1	NULL
may	NULL
affect	NULL
replication	NULL
of	NULL
HIV-1	NULL
at	NULL
several	NULL
different	NULL
stages	NULL
:	NULL
it	NULL
may	NULL
inhibit	NULL
viral	NULL
fusion/entry	NULL
through	NULL
down-regulation	NULL
of	NULL
expression	NULL
of	NULL
CXCR4	NULL
,	NULL
a	NULL
fusion/entry	NULL
cofactor	NULL
for	NULL
T-tropic	NULL
HIV-1	NULL
;	NULL
it	NULL
may	NULL
inhibit	NULL
uncoating	NULL
of	NULL
virions	NULL
through	NULL
interaction	NULL
with	NULL
CyPA	NULL
;	NULL
and	NULL
it	NULL
may	NULL
inhibit	NULL
viral	NULL
expression	NULL
through	NULL
down-regulation	NULL
of	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
.	NULL

It	NULL
remains	NULL
unknown	NULL
whether	NULL
the	NULL
transcription	NULL
factors	NULL
investigated	NULL
in	NULL
this	NULL
study	NULL
can	NULL
actually	NULL
modulate	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CXCR4	NULL
and	NULL
fusogenic-ity	NULL
of	NULL
cells	NULL
with	NULL
T-tropic	NULL
HIV	NULL
Env	NULL
;	NULL
however	NULL
,	NULL
preliminary	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
overexpression	NULL
of	NULL
YY1	NULL
can	NULL
markedly	NULL
decrease	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CXCR4	NULL
(	NULL
D.	NULL
Margolis	NULL
,	NULL
unpublished	NULL
ob-servation	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
YY	NULL
1-mediated	NULL
down-regulation	NULL
of	NULL
CXCR4	NULL
can	NULL
modulate	NULL
fusion/entry	NULL
of	NULL
T-tropic	NULL
HIV-1	NULL
.	NULL

Cellular	NULL
entry	NULL
is	NULL
one	NULL
of	NULL
the	NULL
critical	NULL
events	NULL
during	NULL
the	NULL
HIV-1	NULL
replication	NULL
cycle	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
demonstrating	NULL
that	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
CCR5	NULL
,	NULL
a	NULL
fusion/entry	NULL
cofactor	NULL
for	NULL
macrophage-tropic	NULL
HIV-1	NULL
(	NULL
11-13	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
correlate	NULL
with	NULL
infectability	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
by	NULL
macrophage-tropic	NULL
HIV-1	NULL
in	NULL
vitro	NULL
(	NULL
42	NULL
)	NULL
implies	NULL
that	NULL
levels	NULL
of	NULL
CXCR4	NULL
expression	NULL
may	NULL
also	NULL
influence	NULL
infectability	NULL
of	NULL
cells	NULL
with	NULL
T-tropic	NULL
HIV-1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
from	NULL
previous	NULL
studies	NULL
demonstrating	NULL
that	NULL
SDF-1	NULL
,	NULL
a	NULL
natural	NULL
ligand	NULL
for	NULL
CXCR4	NULL
,	NULL
inhibits	NULL
cellular	NULL
entry	NULL
of	NULL
T-tropic	NULL
HIV-1	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
as	NULL
well	NULL
as	NULL
a	NULL
recent	NULL
study	NULL
showing	NULL
that	NULL
a	NULL
genetic	NULL
variation	NULL
in	NULL
the	NULL
SDF-1	NULL
gene	NULL
is	NULL
associated	NULL
with	NULL
prognosis	NULL
of	NULL
HIV	NULL
disease	NULL
(	NULL
43	NULL
)	NULL
,	NULL
it	NULL
is	NULL
very	NULL
likely	NULL
that	NULL
availability	NULL
of	NULL
functional	NULL
CXCR4	NULL
is	NULL
one	NULL
of	NULL
the	NULL
critical	NULL
parameters	NULL
that	NULL
determine	NULL
the	NULL
rate	NULL
of	NULL
progression	NULL
of	NULL
HIV	NULL
disease	NULL
in	NULL
vivo	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
understand	NULL
the	NULL
molecular	NULL
and	NULL
cellular	NULL
mechanisms	NULL
whereby	NULL
expression	NULL
of	NULL
HIV	NULL
fusion/entry	NULL
cofactors	NULL
is	NULL
regulated	NULL
.	NULL

Further	NULL
char	NULL
5991	NULL
acterization	NULL
of	NULL
the	NULL
promoter	NULL
regions	NULL
for	NULL
these	NULL
cofactors	NULL
will	NULL
help	NULL
delineate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
control	NULL
their	NULL
expression	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
T.	NULL
D.	NULL
Littlewood	NULL
,	NULL
D.	NULL
E.	NULL
Ayer	NULL
,	NULL
M.	NULL
Sawadogo	NULL
,	NULL
and	NULL
T.	NULL
Shenk	NULL
for	NULL
reagents	NULL
,	NULL
and	NULL
J.	NULL
Weddle	NULL
for	NULL
graphic	NULL
work	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Fauci	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

Host	NULL
factors	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV-induced	NULL
disease	NULL
.	NULL

Nature	NULL
384:529	NULL
.	NULL

2	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
326:711	NULL
.	NULL

3	NULL
.	NULL

Ruocco	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
X.	NULL
Chen	NULL
,	NULL
C.	NULL
Ambrosino	NULL
,	NULL
E.	NULL
Dragonetti	NULL
,	NULL
W.	NULL
Liu	NULL
,	NULL
M.	NULL
Mallardo	NULL
,	NULL
G.	NULL
De	NULL
Falco	NULL
,	NULL
C.	NULL
Palmieri	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
I.	NULL
Quinto	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeats	NULL
by	NULL
interaction	NULL
of	NULL
C/EBP	NULL
(	NULL
NE-IL6	NULL
)	NULL
and	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:22479	NULL
.	NULL

4	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
X.	NULL
Zou	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Calame	NULL
.	NULL

1995	NULL
.	NULL

C/EBP	NULL
proteins	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
in	NULL
macrophages/monocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:5337	NULL
.	NULL

5	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
AIDS	NULL
retrovirus	NULL
promoter	NULL
by	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
Sp1	NULL
.	NULL

Science	NULL
232	NULL
:	NULL
755	NULL
.	NULL

6.	NULL
d	NULL
'	NULL
Adda	NULL
di	NULL
Fagagna	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
G.	NULL
Marzio	NULL
,	NULL
M.	NULL
I.	NULL
Gutierrez	NULL
,	NULL
L.	NULL
Y.	NULL
Kang	NULL
,	NULL
A.	NULL
Falaschi	NULL
,	NULL
and	NULL
M.	NULL
Giacca	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
and	NULL
functional	NULL
interactions	NULL
of	NULL
transcription	NULL
factor	NULL
USF	NULL
with	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2765	NULL
.	NULL

7	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
Hwman	NULL
Refroviruses	NULL
.	NULL

B.	NULL
R.	NULL
Cullen	NULL
,	NULL
ed	NULL
.	NULL

IRL	NULL
Press	NULL
,	NULL
Oxford	NULL
,	NULL
pp	NULL
.	NULL

49-73	NULL
.	NULL

8	NULL
.	NULL

Shrivastava	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
genes	NULL
regulated	NULL
by	NULL
the	NULL
multi-factorial	NULL
transcriptional	NULL
regulator	NULL
Yin	NULL
Yang-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:5151	NULL
.	NULL

9	NULL
.	NULL

Margolis	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
Somasundaran	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
transcription	NULL
factor	NULL
YY1	NULL
represses	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
transcription	NULL
and	NULL
virion	NULL
production	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:905	NULL
.	NULL

10	NULL
.	NULL

Romerio	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
N.	NULL
Gabriel	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Margolis	NULL
.	NULL

1997	NULL
.	NULL

Repression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
through	NULL
the	NULL
novel	NULL
cooperation	NULL
of	NULL
human	NULL
factors	NULL
YY1	NULL
and	NULL
LSF	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:9375	NULL
.	NULL

11	NULL
.	NULL

Alkhatib	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
Combadiere	NULL
,	NULL
C.	NULL
C.	NULL
Broder	NULL
,	NULL
Y.	NULL
Feng	NULL
,	NULL
P.	NULL
E.	NULL
Kennedy	NULL
,	NULL
P.	NULL
M.	NULL
Murphy	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Berger	NULL
.	NULL

1996	NULL
.	NULL

CC	NULL
CKR5	NULL
:	NULL
a	NULL
RANTES	NULL
,	NULL
MIP-1	NULL
@	NULL
,	NULL
receptor	NULL
as	NULL
a	NULL
fusion	NULL
cofactor	NULL
for	NULL
macrophage-tropic	NULL
HIV-1	NULL
.	NULL

Science	NULL
272:1955	NULL
.	NULL

12	NULL
.	NULL

Choe	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Farzan	NULL
,	NULL
Y	NULL
.	NULL

Sun	NULL
,	NULL
N.	NULL
Sullivan	NULL
,	NULL
B.	NULL
Rollins	NULL
,	NULL
P.	NULL
D.	NULL
Ponath	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
C.	NULL
R.	NULL
Mackay	NULL
,	NULL
G.	NULL
LaRosa	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
B-chemokine	NULL
receptors	NULL
CCR3	NULL
and	NULL
CCRS	NULL
facilitate	NULL
infection	NULL
by	NULL
primary	NULL
HIV-1	NULL
isolates	NULL
.	NULL

Cell	NULL
85:1135	NULL
.	NULL

13	NULL
.	NULL

Deng	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Liu	NULL
,	NULL
W.	NULL
Ellimeier	NULL
,	NULL
S.	NULL
Choe	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
M.	NULL
Burkhart	NULL
,	NULL
P.	NULL
DiMarzio	NULL
,	NULL
S.	NULL
Marmon	NULL
,	NULL
R.	NULL
E.	NULL
Sutton	NULL
,	NULL
C.	NULL
M.	NULL
Hill	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
major	NULL
coreceptor	NULL
for	NULL
primary	NULL
isolates	NULL
of	NULL
HIV-1	NULL
.	NULL

Nature	NULL
381:661	NULL
.	NULL

14	NULL
.	NULL

Deng	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
V.	NULL
Kewal	NULL
Ramani	NULL
,	NULL
and	NULL
D.	NULL
Littman	NULL
.	NULL

1997	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
new	NULL
receptors	NULL
used	NULL
by	NULL
simian	NULL
and	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
.	NULL

Nature	NULL
388:296	NULL
.	NULL

15	NULL
.	NULL

Doranz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
J.	NULL
Rucker	NULL
,	NULL
Y.	NULL
Yi	NULL
,	NULL
R.	NULL
J.	NULL
Smyth	NULL
,	NULL
M.	NULL
Samson	NULL
,	NULL
S.	NULL
C.	NULL
Peiper	NULL
,	NULL
M.	NULL
Parmentier	NULL
,	NULL
R.	NULL
G.	NULL
Collman	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Dom	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
dual-tropic	NULL
primary	NULL
HIV-1	NULL
isolate	NULL
that	NULL
uses	NULL
fusin	NULL
and	NULL
the	NULL
B-chemokine	NULL
receptors	NULL
CKR-5	NULL
,	NULL
CKR-3	NULL
,	NULL
and	NULL
CKR-2b	NULL
as	NULL
fusion	NULL
cofactors	NULL
.	NULL

Cell	NULL
85:1149	NULL
.	NULL

16	NULL
.	NULL

Dragic	NULL
,	NULL
T.	NULL
,	NULL
V.	NULL
Litwin	NULL
,	NULL
G.	NULL
P.	NULL
Allaway	NULL
,	NULL
S.	NULL
R.	NULL
Martin	NULL
,	NULL
Y.	NULL
Huang	NULL
,	NULL
K.	NULL
A.	NULL
Nagashima	NULL
,	NULL
C.	NULL
Cayanan	NULL
,	NULL
P.	NULL
J.	NULL
Maddon	NULL
,	NULL
R.	NULL
A.	NULL
Koup	NULL
,	NULL
J.	NULL
P.	NULL
Moore	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Paxton	NULL
.	NULL

1996	NULL
.	NULL

HIV-1	NULL
entry	NULL
into	NULL
CD4*	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
chemokine	NULL
receptor	NULL
CC-CKR-5	NULL
.	NULL

Nature	NULL
381:667	NULL
.	NULL

17	NULL
.	NULL

Feng	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Broder	NULL
,	NULL
P.	NULL
E.	NULL
Kennedy	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Berger	NULL
.	NULL

1996	NULL
.	NULL

HIV-1	NULL
entry	NULL
co-factor	NULL
:	NULL
functional	NULL
cDNA	NULL
cloning	NULL
of	NULL
a	NULL
seven-transmembrane	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
.	NULL

Science	NULL
272:872	NULL
.	NULL

18	NULL
.	NULL

Liao	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Alkbatib	NULL
,	NULL
K.	NULL
Peden	NULL
,	NULL
G.	NULL
Sharma	NULL
,	NULL
E.	NULL
Berger	NULL
,	NULL
and	NULL
J.	NULL
Farber	NULL
.	NULL

1997	NULL
.	NULL

STRL33	NULL
,	NULL
a	NULL
novel	NULL
chemokine	NULL
receptor-like	NULL
protein	NULL
,	NULL
functions	NULL
as	NULL
a	NULL
fusion	NULL
cofactor	NULL
for	NULL
both	NULL
macrophage-tropic	NULL
and	NULL
T	NULL
cell	NULL
line-tropic	NULL
HIV-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:2015	NULL
.	NULL

19	NULL
.	NULL

Bleul	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
M.	NULL
Farzan	NULL
,	NULL
H.	NULL
Choe	NULL
,	NULL
C.	NULL
Parolin	NULL
,	NULL
I.	NULL
Clark-Lewis	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
lymphocyte	NULL
chemoattractant	NULL
SDF-1	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
LESTR/fusin	NULL
and	NULL
blocks	NULL
HIV-1	NULL
entry	NULL
.	NULL

Nature	NULL
382:829	NULL
.	NULL

20	NULL
.	NULL

Oberlin	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Amara	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
O.	NULL
Schwartz	NULL
,	NULL
J.-M.	NULL
Heard	NULL
,	NULL
I.	NULL
Clark-Lewis	NULL
,	NULL
D.	NULL
F.	NULL
Legler	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
CXC	NULL
chemokine	NULL
SDF-1	NULL
is	NULL
the	NULL
ligand	NULL
for	NULL
LESTR/fusin	NULL
and	NULL
prevents	NULL
infection	NULL
by	NULL
T-cell-line-adapted	NULL
HIV-1	NULL
.	NULL

Nature	NULL
382:833	NULL
.	NULL

21	NULL
.	NULL

Amara	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
L.	NULL
Gall	NULL
,	NULL
O.	NULL
Schwartz	NULL
,	NULL
J.	NULL
Salamero	NULL
,	NULL
M.	NULL
Montes	NULL
,	NULL
P.	NULL
Loctsher	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Scisdedos	NULL
.	NULL

1997	NULL
.	NULL

HIV	NULL
coreceptor	NULL
down-regulation	NULL
as	NULL
antiviral	NULL
principle	NULL
:	NULL
SDF-la-dependent	NULL
internalization	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
contributes	NULL
to	NULL
inhibition	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:139	NULL
.	NULL

22	NULL
.	NULL

Signoret	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Oldridge	NULL
,	NULL
A.	NULL
Pelchen-Matthews	NULL
,	NULL
P.	NULL
J.	NULL
Klasse	NULL
,	NULL
T.	NULL
Tran	NULL
,	NULL
L.	NULL
F.	NULL
Brass	NULL
,	NULL
M.	NULL
M.	NULL
Rosenkilde	NULL
,	NULL
T.	NULL
W.	NULL
Schwartz	NULL
,	NULL
W.	NULL
Holmes	NULL
,	NULL
W.	NULL
Dallas	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Phorbol	NULL
esters	NULL
and	NULL
SDF-1	NULL
induce	NULL
rapid	NULL
endocytosis	NULL
and	NULL
down-modulation	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

139:651	NULL
.	NULL

23	NULL
.	NULL

Loctscher	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Sictz	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
and	NULL
B.	NULL
Moser	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-2	NULL
regulates	NULL
CC	NULL
chemokine	NULL
receptor	NULL
expression	NULL
and	NULL
chemotactic	NULL
responsiveness	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:569	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
5992	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

Moriuchi	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Moriuchi	NULL
,	NULL
W.	NULL
Turner	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
CXCR4	NULL
,	NULL
a	NULL
coreceptor	NULL
for	NULL
HIV-1	NULL
entry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:4322	NULL
.	NULL

McKnight	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Wilkinson	NULL
,	NULL
G.	NULL
Simmons	NULL
,	NULL
S.	NULL
Talbot	NULL
,	NULL
L.	NULL
Picard	NULL
,	NULL
M.	NULL
Ahuja	NULL
,	NULL
M.	NULL
Marsh	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoxie	NULL
,	NULL
and	NULL
P.	NULL
R.	NULL
Clapham	NULL
.	NULL

1997	NULL
.	NULL

Inhibition	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
fusion	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
a	NULL
coreceptor	NULL
(	NULL
CXCR4	NULL
)	NULL
is	NULL
both	NULL
cell	NULL
type	NULL
and	NULL
virus	NULL
strain	NULL
dependent	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:1692	NULL
.	NULL

Moriuchi	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Moriuchi	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Cohen	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
RING	NULL
finger	NULL
domain	NULL
of	NULL
the	NULL
varicella-zoster	NULL
virus	NULL
open	NULL
reading	NULL
frame	NULL
61	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
its	NULL
transregulatory	NULL
functions	NULL
.	NULL

Virology	NULL
205:238	NULL
.	NULL

Littlewood	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
D.	NULL
C.	NULL
Hancock	NULL
,	NULL
P.	NULL
S.	NULL
Danielian	NULL
,	NULL
M.	NULL
G.	NULL
Parker	NULL
,	NULL
and	NULL
G.	NULL
I.	NULL
Evan	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
modified	NULL
oestrogen	NULL
receptor	NULL
ligand-binding	NULL
domain	NULL
as	NULL
an	NULL
improved	NULL
switch	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
heterologous	NULL
proteins	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:1686	NULL
.	NULL

Ayer	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
C.	NULL
D.	NULL
Laherty	NULL
,	NULL
Q	NULL
.	NULL

A.	NULL
Lawrence	NULL
,	NULL
A.	NULL
P.	NULL
Armstrong	NULL
,	NULL
and	NULL
R.	NULL
N.	NULL
Eisenman	NULL
.	NULL

1996	NULL
.	NULL

Mad	NULL
proteins	NULL
contain	NULL
a	NULL
dominant	NULL
transcription	NULL
repression	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:5772	NULL
.	NULL

Meier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
X.	NULL
Luo	NULL
,	NULL
M.	NULL
Sawadogo	NULL
,	NULL
and	NULL
S.	NULL
E.	NULL
Straus	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
cellular	NULL
transcription	NULL
factor	NULL
USF	NULL
cooperates	NULL
with	NULL
varicella-zoster	NULL
virus	NULL
immediate-early	NULL
protein	NULL
62	NULL
to	NULL
symmetrically	NULL
activate	NULL
a	NULL
bidirectional	NULL
viral	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6896	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
Seto	NULL
,	NULL
L.-S.	NULL
,	NULL
Chang	NULL
,	NULL
and	NULL
T.	NULL
Shenk	NULL
.	NULL

1991	NULL
.	NULL

Transciptional	NULL
repression	NULL
by	NULL
YY1	NULL
,	NULL
a	NULL
human	NULL
GLI-Kruppel-related	NULL
protein	NULL
,	NULL
and	NULL
relief	NULL
of	NULL
repression	NULL
by	NULL
adeno-virus	NULL
E1A	NULL
protein	NULL
.	NULL

Cell	NULL
67:377	NULL
.	NULL

Moriuchi	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Moriuchi	NULL
,	NULL
C.	NULL
Combadiere	NULL
,	NULL
P.	NULL
M.	NULL
Murphy	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1996	NULL
.	NULL

CD8	NULL
*	NULL
T-cell-derived	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
but	NULL
not	NULL
B-chemokines	NULL
RANTES	NULL
,	NULL
MIP-1	NULL
@	NULL
,	NULL
and	NULL
MIP-13	NULL
,	NULL
suppress	NULL
HIV-1	NULL
replication	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:15341	NULL
.	NULL

Moriuchi	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Moriuchi	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
B	NULL
potently	NULL
up-regulates	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
RANTES	NULL
,	NULL
a	NULL
chemokine	NULL
that	NULL
blocks	NULL
HIV	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:3483	NULL
.	NULL

Moriuchi	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Moriuchi	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Cohen	NULL
.	NULL

1995	NULL
.	NULL

Proteins	NULL
and	NULL
cis-acting	NULL
elements	NULL
associated	NULL
with	NULL
transactivation	NULL
of	NULL
the	NULL
varicella-zoster	NULL
virus	NULL
(	NULL
VZV	NULL
)	NULL
immediate-early	NULL
gene	NULL
62	NULL
promoter	NULL
by	NULL
VZV	NULL
open	NULL
reading	NULL
frame	NULL
10	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:4693	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

REGULATION	NULL
OF	NULL
CXCR4	NULL
PROMOTER	NULL
BY	NULL
USF/c-Mye	NULL
AND	NULL
YY1	NULL
Moriuchi	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Mortuchi	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
for	NULL
CCR5	NULL
,	NULL
a	NULL
coreceptor	NULL
for	NULL
HIV-1	NULL
entry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5441	NULL
.	NULL

Bleul	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoxie	NULL
,	NULL
T.	NULL
A.	NULL
Springer	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Mackay	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
HIV	NULL
coreceptors	NULL
CXCR4	NULL
and	NULL
CCRS	NULL
are	NULL
differently	NULL
expressed	NULL
and	NULL
regulated	NULL
on	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:1925	NULL
.	NULL

Luscher	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Austin	NULL
,	NULL
A.	NULL
Sommer	NULL
,	NULL
S.	NULL
Hilfenhaus	NULL
,	NULL
and	NULL
M.	NULL
Henriksson	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
by	NULL
the	NULL
Myc-Max/Mad	NULL
network	NULL
.	NULL

In	NULL
Transcription	NULL
Factors	NULL
in	NULL
Eukaryotes	NULL
.	NULL

A.	NULL
G.	NULL
Papavassiliou	NULL
,	NULL
ed	NULL
.	NULL

R.	NULL
G.	NULL
Land	NULL
Company	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Shrivastava	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Saleque	NULL
,	NULL
G.	NULL
V.	NULL
Kalpana	NULL
,	NULL
S.	NULL
Artandi	NULL
,	NULL
S.	NULL
P.	NULL
Goff	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
transcriptional	NULL
regulator	NULL
Yin-Yang-1	NULL
by	NULL
association	NULL
with	NULL
c-Myc	NULL
.	NULL

Science	NULL
262:1889	NULL
.	NULL

Ayer	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
N.	NULL
Eisenman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
switch	NULL
from	NULL
Myc	NULL
:	NULL
Max	NULL
to	NULL
Mad	NULL
:	NULL
Max	NULL
heterocomplexes	NULL
accompanies	NULL
monocyte/macrophage	NULL
differentiation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2110	NULL
.	NULL

Yang	NULL
,	NULL
W.-M.	NULL
,	NULL
C.	NULL
J.	NULL
Inouye	NULL
,	NULL
and	NULL
E.	NULL
Seto	NULL
.	NULL

1995	NULL
.	NULL

Cyclophilin	NULL
A	NULL
and	NULL
FKBP12	NULL
interact	NULL
with	NULL
YY1	NULL
and	NULL
alter	NULL
its	NULL
transcriptional	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:15187	NULL
.	NULL

Franke	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
H.	NULL
E.	NULL
H.	NULL
Yuan	NULL
,	NULL
and	NULL
J.	NULL
Luban	NULL
.	NULL

1994	NULL
.	NULL

Specific	NULL
incorporation	NULL
of	NULL
cyclophilin	NULL
A	NULL
into	NULL
HIV-1	NULL
virions	NULL
.	NULL

Nature	NULL
372:359	NULL
.	NULL

Thali	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Bukovsky	NULL
,	NULL
E.	NULL
Kondo	NULL
,	NULL
B.	NULL
Rosenwirth	NULL
,	NULL
C.	NULL
T.	NULL
Walsh	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
and	NULL
H.	NULL
G.	NULL
Gotflinger	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
association	NULL
of	NULL
cyclophilin	NULL
A	NULL
with	NULL
HIV-1	NULL
virions	NULL
.	NULL

Nature	NULL
372:363	NULL
.	NULL

Wu	NULL
,	NULL
L.	NULL
,	NULL
W.	NULL
A.	NULL
Paxton	NULL
,	NULL
N.	NULL
Kassam	NULL
,	NULL
N.	NULL
Ruffing	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Rottman	NULL
,	NULL
N.	NULL
Sullivan	NULL
,	NULL
H.	NULL
Choe	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
W.	NULL
Neuman	NULL
,	NULL
R.	NULL
A.	NULL
Koup	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Mackay	NULL
.	NULL

1997	NULL
.	NULL

CCRS	NULL
levels	NULL
and	NULL
expression	NULL
pattern	NULL
correlate	NULL
with	NULL
infectability	NULL
by	NULL
macrophage-tropic	NULL
HIV-1	NULL
,	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1681	NULL
.	NULL

Winkler	NULL
,	NULL
C.	NULL
,	NULL
W.	NULL
Modi	NULL
,	NULL
M.	NULL
W.	NULL
Smith	NULL
,	NULL
G.	NULL
W.	NULL
Nelson	NULL
,	NULL
X.	NULL
Wu	NULL
,	NULL
M.	NULL
Carrington	NULL
,	NULL
M.	NULL
Dean	NULL
,	NULL
T.	NULL
Honjo	NULL
,	NULL
K.	NULL
Tashiro	NULL
,	NULL
D.	NULL
Yabe	NULL
et	NULL
al	NULL
,	NULL
ALIVE	NULL
Study	NULL
,	NULL
Hemophilia	NULL
Growth	NULL
and	NULL
Development	NULL
Study	NULL
(	NULL
HGDS	NULL
)	NULL
,	NULL
Multicenter	NULL
AIDS	NULL
Cohort	NULL
Study	NULL
(	NULL
MACS	NULL
)	NULL
,	NULL
Multicenter	NULL
Hemophilia	NULL
Cohort	NULL
Study	NULL
(	NULL
MHCS	NULL
)	NULL
,	NULL
and	NULL
San	NULL
Francisco	NULL
City	NULL
Cohort	NULL
(	NULL
SECC	NULL
)	NULL
.	NULL

1998	NULL
.	NULL

Genetic	NULL
restriction	NULL
of	NULL
AIDS	NULL
pathogenesis	NULL
by	NULL
an	NULL
SDF-1	NULL
chemokine	NULL
gene	NULL
variant	NULL
.	NULL

Science	NULL
279:389	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

